Related Experiment Videos
Adriamycin-activated macrophages as tumor growth inhibitors
Abstract:
Flow cytometry has been used to study the influence of Adriamycin- and Corynebacterium parvum-elicited cytostatic macrophages on the cell cycle of HeLa cells. Macrophages harvested from the peritoneal cavity of mice given i.p. injections of Adriamycin retain cytostatic activity for 3 to 4 days in vivo. Many of these macrophages fluoresced with the red emission spectra characteristic of Adriamycin. The decline in the presence of macrophages exhibiting red fluorescent cytoplasmic particles paralleled the loss in cytostatic activity. Drug-induced cytostatic macrophages exhibited at least as high a level of growth inhibition as did C. parvum-activated cells. In contrast to the apparent G1 block of HeLa cells which resulted from interaction wih C. parvum-activated macrophages. Adriamycin-stimulated macrophages inhibited growth in the G2-M phase characteristic of the free drug. Multiple freeze-thaw cycles removed all activity from C. parvum macrophages but had no influence on the Adriamycin-elicited effector cell activity. The data suggest that in vivo drug storage by macrophages may represent an important step in tumor cell destruction by Adriamycin.
Insights
Adriamycin-stimulated macrophages exhibit potent cytostatic activity against HeLa cells, primarily by inhibiting the G2-M phase. This suggests in vivo drug storage by macrophages is key for Adriamycin
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Macrophages play a role in drug-mediated tumor destruction.
- Adriamycin and Corynebacterium parvum (C. parvum) can activate macrophages.
Purpose of the Study:
- To investigate the influence of Adriamycin- and C. parvum-elicited cytostatic macrophages on the cell cycle of HeLa cells.
- To compare the efficacy and mechanisms of Adriamycin- and C. parvum-activated macrophages.
Main Methods:
- Flow cytometry was used to analyze HeLa cell cycle progression.
- Macrophages were harvested from mice treated with Adriamycin or C. parvum.
- Cytostatic activity and cell cycle effects were assessed in vitro.
Main Results:
- Adriamycin-stimulated macrophages retained cytostatic activity for 3-4 days in vivo.
- Adriamycin-elicited macrophages showed red fluorescence, correlating with cytostatic activity.
- Both Adriamycin- and C. parvum-activated macrophages inhibited HeLa cell growth.
- Adriamycin-stimulated macrophages induced a G2-M phase block, similar to free Adriamycin.
- C. parvum-activated macrophages induced a G1 phase block.
- Adriamycin-elicited macrophage activity was resistant to freeze-thaw cycles, unlike C. parvum-activated macrophages.
Conclusions:
- In vivo drug storage by macrophages is a significant mechanism for Adriamycin-mediated tumor cell destruction.
- Adriamycin-stimulated macrophages offer a more robust and stable form of cytostasis compared to C. parvum-activated macrophages.